With one platform and a single product owner, multiple business units now track, log, and share their innovation activity, giving leadership a complete picture of company-wide startup engagement.
Large pharmaceutical organizations run innovation activity across many business units simultaneously. Each team pursues its own pipeline, tracks its own vendors, and builds its own startup relationships. Without a shared system, no one has a complete view of what the company is exploring, where work overlaps, or what has already been evaluated and by whom.
The result is duplicated effort, missed collaboration opportunities, and an innovation leader who cannot credibly answer the question: what is our company actually doing in any given technology area?
Teams retain full autonomy over their own innovation pipelines while the organization gains something it did not have before: a complete, real-time picture of where startup exploration is happening, what has been evaluated, and what relationships are in progress. Cross-functional understanding of focus areas has improved, and the possibility of collaboration across teams on overlapping technology problems is now discoverable.